Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Antiviral Res. 2016 Apr 26;131:92–99. doi: 10.1016/j.antiviral.2016.04.013

Table 2.

In vitro activities of purified MAbs

MAb ELISAa PRNT90b PRNT/ELISA
Ratio
m864 0.005 μg/ml 0.1 μg/ml 20
864-cIgG 0.08 μg/ml 10 μg/ml 125
2C9-cIgG 0.25 μg/ml > 10 μg/ml >40
a

ELISA endpoint titers in μg/ml of MAb using purified 17D-204 as antigen.

b

90% plaque-reduction neutralization test end-point titers in μg/ml MAb